
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 926 | 926 | 939 | 961 | 1609 | 2217 |
Fund Return | -7.4% | -7.4% | -6.1% | -1.3% | 9.97% | 8.29% |
Place in category | 165 | 165 | 331 | 366 | 321 | 191 |
% in Category | 42 | 42 | 66 | 79 | 78 | 53 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 22.54B | 5.54 | 9.97 | 7.95 | ||
Artisan International Value Advisor | 11.43B | 5.50 | 9.87 | - | ||
Artisan Mid Cap Advisor | 3.59B | -7.37 | -1.17 | - | ||
Artisan Mid Cap Institutional | 3.59B | -7.35 | -1.08 | 8.54 | ||
Artisan International Small Cap Ins | 2.75B | -1.38 | -1.44 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14B | -0.40 | 9.34 | 11.64 | ||
Vanguard Mid-Cap Growth Index Admir | 12.89B | -3.45 | 3.95 | 9.37 | ||
T. Rowe Price Mid-Cap Growth I | 10.72B | -7.10 | 2.27 | - | ||
T. Rowe Price Mid-Cap Growth | 9.94B | -7.13 | 2.13 | 8.74 | ||
Janus Enterprise I | 9.01B | -4.03 | 5.61 | 11.02 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 4.97 | 605.38 | -0.17% | |
Spotify Tech | LU1778762911 | 4.20 | 572.39 | +4.23% | |
West Pharmaceutical Services | US9553061055 | 3.84 | 212.50 | -0.08% | |
Tyler Technologies | US9022521051 | 3.64 | 578.43 | +1.16% | |
Ascendis Pharma AS | US04351P1012 | 3.22 | 153.92 | -1.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Sell | Strong Sell | Strong Sell |
Summary | Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review